Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,836
Closed -$659K 289
2018
Q2
$659K Buy
9,836
+6,400
+186% +$438K 0.1% 250
2018
Q1
$286K Buy
+3,436
New +$310K 0.03% 311
2017
Q2
Sell
-2,373
Closed -$317K 712
2017
Q1
$317K Sell
2,373
-969
-29% -$123K 0.02% 754
2016
Q4
$335K Sell
3,342
-14,825
-82% -$1.45M 0.02% 668
2016
Q3
$1.71M Buy
+18,167
New +$1.53M 0.08% 319
2014
Q2
Sell
-11,640
Closed -$623K 368
2014
Q1
$623K Buy
11,640
+2,571
+28% +$160K 0.23% 115
2013
Q4
$459K Buy
+9,069
New +$395K 0.15% 171
2013
Q3
Sell
-17,247
Closed -$379K 368
2013
Q2
$379K Buy
+17,247
New +$377K 0.12% 169

Other funds holding INCY

Clinton Group's INCY Position: Q3 2018 in Review

Clinton Group sold out of Incyte (INCY) in Q3 2018, closing a stake of 9,836 shares — an estimated $659K sold.

Clinton Group first reported a position in INCY in Q2 2013 and held it in 8 quarters. The position peaked at $1.71M in Q3 2016. 461 funds tracked by Wall St. Rank hold INCY as of Q3 2018.

  • Clinton Group reported no remaining Incyte position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 9,836 Incyte shares in Q3 2018, an estimated $659K.
  • Clinton Group first reported a position in Incyte in Q2 2013 and held it in 8 quarters.
  • Clinton Group's Incyte position peaked at $1.71M in Q3 2016.
  • 461 funds tracked by Wall St. Rank held Incyte as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.